{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:32:19Z","timestamp":1791052339096,"version":"4.1.0"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2010,10,5]],"date-time":"2010-10-05T00:00:00Z","timestamp":1286236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1038\/nrcardio.2010.144","type":"journal-article","created":{"date-parts":[[2010,10,5]],"date-time":"2010-10-05T14:16:40Z","timestamp":1286288200000},"page":"648-659","source":"Crossref","is-referenced-by-count":112,"title":["Pulmonary hypertension with left-sided heart disease"],"prefix":"10.1038","volume":"7","author":[{"given":"Marco","family":"Guazzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Arena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,10,5]]},"reference":[{"key":"BFnrcardio2010144_CR1","unstructured":"WHO. Executive summary from the World Symposium on Primary Pulmonary Hypertension (WHO, Evian, 1998)."},{"key":"BFnrcardio2010144_CR2","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jacc.2004.02.037","volume":"43","author":"G Simonneau","year":"2004","unstructured":"Simonneau, G. et al. Clinical classification of pulmonary hypertension. J. Am. Coll. Cardiol. 43, 5S\u201312S (2004).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR3","first-page":"1544","volume-title":"Textbook of Respiratory Medicine","author":"T De Marco","year":"2005","unstructured":"De Marco, T. & Rapaport, E. in Textbook of Respiratory Medicine 4th edn Ch. 52 (eds Mason, R. J., Broaddus, V. C., Murray, J. F. & Nadel, J. A.) 1544\u20131569 (Elsevier Saunders, Philadelphia, 2005)."},{"issue":"Suppl. 1","key":"BFnrcardio2010144_CR4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2006.09.011","volume":"119","author":"M Gheorghiade","year":"2006","unstructured":"Gheorghiade, M., Filippatos, G., De Luca, L. & Burnett, J. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am. J. Med. 119 (Suppl. 1), S3\u2013S10 (2006).","journal-title":"Am. J. Med."},{"key":"BFnrcardio2010144_CR5","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1067\/mhj.2000.110933","volume":"140","author":"C Lucas","year":"2000","unstructured":"Lucas, C. et al. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am. Heart J. 140, 840\u2013847 (2000).","journal-title":"Am. Heart J."},{"key":"BFnrcardio2010144_CR6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM200101043440103","volume":"344","author":"SK Gandhi","year":"2001","unstructured":"Gandhi, S. K. et al. The pathogenesis of acute pulmonary edema associated with hypertension. N. Engl. J. Med. 344, 17\u201322 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2010144_CR7","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJMcp022709","volume":"351","author":"GP Aurigemma","year":"2004","unstructured":"Aurigemma, G. P. & Gaasch, W. H. Clinical practice. Diastolic heart failure. N. Engl. J. Med. 351, 1097\u20131105 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2010144_CR8","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.jacc.2003.11.040","volume":"43","author":"M Klapholz","year":"2004","unstructured":"Klapholz, M. et al. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. J. Am. Coll. Cardiol. 43, 1432\u20131438 (2004).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR9","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.amjcard.2006.11.052","volume":"99","author":"J Kjaergaard","year":"2007","unstructured":"Kjaergaard, J. et al. Prognostic importance of pulmonary hypertension in patients with heart failure. Am. J. Cardiol. 99, 1146\u20131150 (2007).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio2010144_CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.21693\/1933-088X-5.1.13","volume":"5","author":"BP Shapiro","year":"2006","unstructured":"Shapiro, B. P., Nishimura, R. A., McGoon, M. D. & Redfield, M. M. Diagnostic dilemmas: diastolic heart failure causing pulmonary hypertension and pulmonary hypertension causing diastolic dysfunction. Adv. Pulmon. Hypertens. 5, 13\u201320 (2006).","journal-title":"Adv. Pulmon. Hypertens."},{"key":"BFnrcardio2010144_CR11","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jacc.2008.11.051","volume":"53","author":"CS Lam","year":"2009","unstructured":"Lam, C. S. et al. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J. Am. Coll. Cardiol. 53, 1119\u20131126 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR12","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/j.jacc.2009.04.008","volume":"54","author":"MM Hoeper","year":"2009","unstructured":"Hoeper, M. M. et al. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J. Am. Coll. Cardiol. 54, S85\u2013S96 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR13","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.cardfail.2008.06.004","volume":"14","author":"M Guazzi","year":"2008","unstructured":"Guazzi, M. Alveolar gas diffusion abnormalities in heart failure. J. Card. Fail. 14, 695\u2013702 (2008).","journal-title":"J. Card. Fail."},{"key":"BFnrcardio2010144_CR14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/01.RES.0000255690.03436.ae","volume":"100","author":"WC Aird","year":"2007","unstructured":"Aird, W. C. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ. Res. 100, 174\u2013190 (2007).","journal-title":"Circ. Res."},{"key":"BFnrcardio2010144_CR15","first-page":"50","volume":"5","author":"C Crone","year":"1990","unstructured":"Crone, C., Saumon, G. & Basset, G. News from the alveoli. News Physiol. Sci. 5, 50\u201353 (1990).","journal-title":"News Physiol. Sci."},{"key":"BFnrcardio2010144_CR16","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/01.CIR.92.3.622","volume":"92","author":"JB West","year":"1995","unstructured":"West, J. B. & Mathieu-Costello, O. Vulnerability of pulmonary capillaries in heart disease. Circulation 92, 622\u2013631 (1995).","journal-title":"Circulation"},{"key":"BFnrcardio2010144_CR17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1152\/jappl.1991.71.2.573","volume":"71","author":"K Tsukimoto","year":"1991","unstructured":"Tsukimoto, K., Mathieu-Costello, O., Prediletto, R., Elliott, A. R. & West, J. B. Ultrastructural appearances of pulmonary capillaries at high transmural pressures. J. Appl. Physiol. 71, 573\u2013582 (1991).","journal-title":"J. Appl. Physiol."},{"key":"BFnrcardio2010144_CR18","doi-asserted-by":"crossref","first-page":"L766","DOI":"10.1152\/ajplung.00313.2001","volume":"282","author":"E Conforti","year":"2002","unstructured":"Conforti, E., Fenoglio, C., Bernocchi, G., Bruschi, O. & Miserocchi, G. A. Morpho-functional analysis of lung tissue in mild interstitial edema. Am. J. Physiol. Lung Cell. Mol. Physiol. 282, L766\u2013L774 (2002).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"BFnrcardio2010144_CR19","first-page":"H2000","volume":"270","author":"D Negrini","year":"1996","unstructured":"Negrini, D., Passi, A., de Luca, G. & Miserocchi, G. Pulmonary interstitial pressure and proteoglycans during development of pulmonary edema. Am. J. Physiol. 270, H2000\u2013H2007 (1996).","journal-title":"Am. J. Physiol."},{"key":"BFnrcardio2010144_CR20","doi-asserted-by":"crossref","first-page":"L1382","DOI":"10.1152\/ajplung.00447.2001","volume":"282","author":"P Palestini","year":"2002","unstructured":"Palestini, P. et al. Composition, biophysical properties, and morphometry of plasma membranes in pulmonary interstitial edema. Am. J. Physiol. Lung Cell. Mol. Physiol. 282, L1382\u2013L1390 (2002).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"BFnrcardio2010144_CR21","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/01.CIR.0000140260.73611.FA","volume":"110","author":"CG De Pasquale","year":"2004","unstructured":"De Pasquale, C. G. et al. Plasma surfactant protein-B: a novel biomarker in chronic heart failure. Circulation 110, 1091\u20131096 (2004).","journal-title":"Circulation"},{"key":"BFnrcardio2010144_CR22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/01.RES.77.2.317","volume":"77","author":"MI Townsley","year":"1995","unstructured":"Townsley, M. I., Fu, Z., Mathieu-Costello, O. & West, J. B. Pulmonary microvascular permeability. Responses to high vascular pressure after induction of pacing-induced heart failure in dogs. Circ. Res. 77, 317\u2013325 (1995).","journal-title":"Circ. Res."},{"key":"BFnrcardio2010144_CR23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/path.1711110404","volume":"111","author":"JM Kay","year":"1973","unstructured":"Kay, J. M. & Edwards, F. R. Ultrastructure of the alveolar-capillary wall in mitral stenosis. J. Pathol. 111, 239\u2013245 (1973).","journal-title":"J. Pathol."},{"key":"BFnrcardio2010144_CR24","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1253\/jcj.43.945","volume":"43","author":"YS Lee","year":"1979","unstructured":"Lee, Y. S. Electron microscopic studies on the alveolar-capillary barrier in the patients of chronic pulmonary edema. Jpn Circ. J. 43, 945\u2013954 (1979).","journal-title":"Jpn Circ. J."},{"key":"BFnrcardio2010144_CR25","first-page":"223","volume":"17","author":"RE Drake","year":"2002","unstructured":"Drake, R. E. & Doursout, M. F. Pulmonary edema and elevated left atrial pressure: four hours and beyond. News Physiol. Sci. 17, 223\u2013226 (2002).","journal-title":"News Physiol. Sci."},{"key":"BFnrcardio2010144_CR26","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1164\/ajrccm.158.6.9804076","volume":"158","author":"JT Berg","year":"1998","unstructured":"Berg, J. T., Breen, E. C., Fu, Z., Mathieu-Costello, O. & West, J. B. Alveolar hypoxia increases gene expression of extracellular matrix proteins and platelet-derived growth factor-B in lung parenchyma. Am. J. Respir. Crit. Care Med. 158, 1920\u20131928 (1998).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrcardio2010144_CR27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1053\/euhj.2001.2803","volume":"23","author":"M Guazzi","year":"2002","unstructured":"Guazzi, M., Pontone, G., Brambilla, R., Agostoni, P. & R\u00e8ina, G. Alveolar-capillary membrane gas conductance: a novel prognostic indicator in chronic heart failure. Eur. Heart J. 23, 467\u2013476 (2002).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio2010144_CR28","first-page":"L5","volume":"277","author":"M Rabinovitch","year":"1999","unstructured":"Rabinovitch, M. EVE and beyond, retro and prospective insights. Am. J. Physiol. 277, L5\u2013L12 (1999).","journal-title":"Am. J. Physiol."},{"key":"BFnrcardio2010144_CR29","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1161\/CIRCULATIONAHA.107.723007","volume":"118","author":"S Rich","year":"2008","unstructured":"Rich, S. & Rabinovitch, M. Diagnosis and treatment of secondary (non-category 1) pulmonary hypertension. Circulation 118, 2190\u20132199 (2008).","journal-title":"Circulation"},{"key":"BFnrcardio2010144_CR30","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0735-1097(01)01486-3","volume":"38","author":"B Stobierska-Dzierzek","year":"2001","unstructured":"Stobierska-Dzierzek, B., Awad, H. & Michler, R. E. The evolving management of acute right-sided heart failure in cardiac transplant recipients. J. Am. Coll. Cardiol. 38, 923\u2013931 (2001).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR31","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1056\/NEJMoa021650","volume":"348","author":"L Du","year":"2003","unstructured":"Du, L. et al. Signaling molecules in nonfamilial pulmonary hypertension. N. Engl. J. Med. 348, 500\u2013509 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2010144_CR32","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1161\/01.CIR.0000034444.31846.F4","volume":"106","author":"H Ooi","year":"2002","unstructured":"Ooi, H., Colucci, W. S. & Givertz, M. M. Endothelin mediates increased pulmonary vascular tone in patients with heart failure: demonstration by direct intrapulmonary infusion of sitaxsentan. Circulation 106, 1618\u20131621 (2002).","journal-title":"Circulation"},{"key":"BFnrcardio2010144_CR33","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0002-9149(98)00400-7","volume":"82","author":"CJ Cooper","year":"1998","unstructured":"Cooper, C. J. et al. The influence of basal nitric oxide activity on pulmonary vascular resistance in patients with congestive heart failure. Am. J. Cardiol. 82, 609\u2013614 (1998).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio2010144_CR34","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1161\/01.CIR.89.5.2035","volume":"89","author":"JS Stamler","year":"1994","unstructured":"Stamler, J. S., Loh, E., Roddy, M. A., Currie, K. E. & Creager, M. A. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 89, 2035\u20132040 (1994).","journal-title":"Circulation"},{"key":"BFnrcardio2010144_CR35","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0735-1097(96)00218-5","volume":"28","author":"ML Blitzer","year":"1996","unstructured":"Blitzer, M. L., Loh, E., Roddy, M. A., Stamler, J. S. & Creager, M. A. Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans. J. Am. Coll. Cardiol. 28, 591\u2013596 (1996).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR36","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1748-1716.2008.01939.x","volume":"196","author":"M Guazzi","year":"2009","unstructured":"Guazzi, M., Arena, R., Vicenzi, M. & Guazzi, M. D. Regulation of alveolar gas conductance by NO in man, as based on studies with NO donors and inhibitors of NO production. Acta Physiol. (Oxf.) 196, 267\u2013277 (2009).","journal-title":"Acta Physiol. (Oxf.)"},{"key":"BFnrcardio2010144_CR37","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/0735-1097(93)90552-C","volume":"22","author":"TR Porter","year":"1993","unstructured":"Porter, T. R. et al. Endothelium-dependent pulmonary artery responses in chronic heart failure: influence of pulmonary hypertension. J. Am. Coll. Cardiol. 22, 1418\u20131424 (1993).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR38","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","volume":"332","author":"M Yanagisawa","year":"1988","unstructured":"Yanagisawa, M. et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411\u2013415 (1988).","journal-title":"Nature"},{"key":"BFnrcardio2010144_CR39","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1152\/jappl.1994.76.5.1976","volume":"76","author":"T Fukuroda","year":"1994","unstructured":"Fukuroda, T. et al. Endothelin receptor subtypes in human versus rabbit pulmonary arteries. J. Appl. Physiol. 76, 1976\u20131982 (1994).","journal-title":"J. Appl. Physiol."},{"key":"BFnrcardio2010144_CR40","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","volume":"328","author":"A Giaid","year":"1993","unstructured":"Giaid, A. et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N. Engl. J. Med. 328, 1732\u20131739 (1993).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2010144_CR41","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1113\/expphysiol.2007.040469","volume":"93","author":"L Ray","year":"2008","unstructured":"Ray, L. et al. Early increase in pulmonary vascular reactivity with overexpression of endothelin-1 and vascular endothelial growth factor in canine experimental heart failure. Exp. Physiol. 93, 434\u2013442 (2008).","journal-title":"Exp. Physiol."},{"key":"BFnrcardio2010144_CR42","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.CIR.85.2.504","volume":"85","author":"RJ Cody","year":"1992","unstructured":"Cody, R. J., Haas, G. J., Binkley, P. F., Capers, Q. & Kelley, R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 85, 504\u2013509 (1992).","journal-title":"Circulation"},{"key":"BFnrcardio2010144_CR43","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0735-1097(98)00437-9","volume":"32","author":"M H\u00fclsmann","year":"1998","unstructured":"H\u00fclsmann, M. et al. Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure. J. Am. Coll. Cardiol. 32, 1695\u20131700 (1998).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR44","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/01.CIR.0000094397.19932.78","volume":"108","author":"S Rich","year":"2003","unstructured":"Rich, S. & McLaughlin, V. V. Endothelin receptor blockers in cardiovascular disease. Circulation 108, 2184\u20132190 (2003).","journal-title":"Circulation"},{"key":"BFnrcardio2010144_CR45","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S1053-2498(99)00070-4","volume":"18","author":"MH Drazner","year":"1999","unstructured":"Drazner, M. H. et al. Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure. J. Heart Lung Transplant. 18, 1126\u20131132 (1999).","journal-title":"J. Heart Lung Transplant."},{"key":"BFnrcardio2010144_CR46","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1161\/CIRCHEARTFAILURE.109.876649","volume":"3","author":"MH Drazner","year":"2010","unstructured":"Drazner, M. H. et al. The relationship of right- and left-sided filling pressures in patients with heart failure and a preserved ejection fraction. Circ. Heart Fail. 3, 202\u2013206 (2010).","journal-title":"Circ. Heart Fail."},{"key":"BFnrcardio2010144_CR47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0735-1097(96)00436-6","volume":"29","author":"M Enriquez-Sarano","year":"1997","unstructured":"Enriquez-Sarano, M., Rossi, A., Seward, J. B., Bailey, K. R. & Tajik, A. J. Determinants of pulmonary hypertension in left ventricular dysfunction. J. Am. Coll. Cardiol. 29, 153\u2013159 (1997).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR48","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/00000542-197608000-00005","volume":"45","author":"N Buchbinder","year":"1976","unstructured":"Buchbinder, N. & Ganz, W. Hemodynamic monitoring: invasive techniques. Anesthesiology 45, 146\u2013155 (1976).","journal-title":"Anesthesiology"},{"key":"BFnrcardio2010144_CR49","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1183\/09031936.02.00068002","volume":"20","author":"D Chemla","year":"2002","unstructured":"Chemla, D., Castelain, V., Herv\u00e9, P., Lecarpentier, Y. & Brimioulle, S. Haemodynamic evaluation of pulmonary hypertension. Eur. Respir. J. 20, 1314\u20131331 (2002).","journal-title":"Eur. Respir. J."},{"key":"BFnrcardio2010144_CR50","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/S0735-1097(98)00091-6","volume":"31","author":"SA Kafi","year":"1998","unstructured":"Kafi, S. A., M\u00e9lot, C., Vachi\u00e9ry, J. L., Brimioulle, S. & Naeije, R. Partitioning of pulmonary vascular resistance in primary pulmonary hypertension. J. Am. Coll. Cardiol. 31, 1372\u20131376 (1998).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR51","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1378\/chest.99.3.715","volume":"99","author":"JR Klinger","year":"1991","unstructured":"Klinger, J. R. & Hill, N. S. Right ventricular dysfunction in chronic obstructive pulmonary disease. Chest 99, 715\u2013723 (1991).","journal-title":"Chest"},{"key":"BFnrcardio2010144_CR52","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1161\/01.RES.2.4.326","volume":"2","author":"AC Guyton","year":"1954","unstructured":"Guyton, A. C., Lindsey, A. W. & Gilluly, J. J. The limits of right ventricular compensation following acute increase in pulmonary circulatory resistance. Circ. Res. 2, 326\u2013332 (1954).","journal-title":"Circ. Res."},{"key":"BFnrcardio2010144_CR53","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0735-1097(00)00698-7","volume":"36","author":"M Guazzi","year":"2000","unstructured":"Guazzi, M. et al. How the left and right sides of the heart, as well as pulmonary venous drainage, adapt to an increasing degree of head-up tilting in hypertrophic cardiomyopathy: differences from the normal heart. J. Am. Coll. Cardiol. 36, 185\u2013193 (2000).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR54","first-page":"398","volume-title":"The Kidney","author":"KL Skorecki","year":"2008","unstructured":"Skorecki, K. L., Winaver, J. & Abassi, Z. in The Kidney 8th edn Ch. 12 (ed. Brenner, B. M.) 398\u2013458 (Saunders, Philadelphia, 2008)."},{"key":"BFnrcardio2010144_CR55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0002-9343(93)90119-A","volume":"94","author":"G Marenzi","year":"1993","unstructured":"Marenzi, G. et al. Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: effects of extracorporeal ultrafiltration. Am. J. Med. 94, 49\u201356 (1993).","journal-title":"Am. J. Med."},{"key":"BFnrcardio2010144_CR56","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/hrt.72.6.534","volume":"72","author":"MD Guazzi","year":"1994","unstructured":"Guazzi, M. D. et al. Apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention. Br. Heart J. 72, 534\u2013539 (1994).","journal-title":"Br. Heart J."},{"key":"BFnrcardio2010144_CR57","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0735-1097(00)01102-5","volume":"37","author":"S Ghio","year":"2001","unstructured":"Ghio, S. et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J. Am. Coll. Cardiol. 37, 183\u2013188 (2001).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR58","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0735-1097(83)80156-9","volume":"2","author":"JF Polak","year":"1983","unstructured":"Polak, J. F., Holman, B. L., Wynne, J. & Colucci, W. S. Right ventricular ejection fraction: an indicator of increased mortality in patients with congestive heart failure associated with coronary artery disease. J. Am. Coll. Cardiol. 2, 217\u2013224 (1983).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR59","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/0735-1097(94)00511-N","volume":"25","author":"TG Di Salvo","year":"1995","unstructured":"Di Salvo, T. G., Mathier, M., Semigran, M. J. & Dec, G. W. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J. Am. Coll. Cardiol. 25, 1143\u20131153 (1995).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR60","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0002-9149(97)00780-7","volume":"80","author":"JP Sun","year":"1997","unstructured":"Sun, J. P. et al. Comparison of mortality rates and progression of left ventricular dysfunction in patients with idiopathic dilated cardiomyopathy and dilated versus nondilated right ventricular cavities. Am. J. Cardiol. 80, 1583\u20131587 (1997).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio2010144_CR61","first-page":"774","volume":"16","author":"A Gavazzi","year":"1997","unstructured":"Gavazzi, A. et al. Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure. J. Heart Lung Transplant. 16, 774\u2013785 (1997).","journal-title":"J. Heart Lung Transplant."},{"key":"BFnrcardio2010144_CR62","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1161\/01.CIR.94.12.3190","volume":"94","author":"J Gorcsan 3rd","year":"1996","unstructured":"Gorcsan, J. 3rd, Murali, S., Counihan, P. J., Mandarino, W. A. & Kormos, R. L. Right ventricular performance and contractile reserve in patients with severe heart failure. Assessment by pressure-area relations and association with outcome. Circulation 94, 3190\u20133197 (1996).","journal-title":"Circulation"},{"key":"BFnrcardio2010144_CR63","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S0735-1097(98)00337-4","volume":"32","author":"P de Groote","year":"1998","unstructured":"de Groote, P. et al. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J. Am. Coll. Cardiol. 32, 948\u2013954 (1998).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR64","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.echo.2005.02.004","volume":"18","author":"J Meluzin","year":"2005","unstructured":"Meluzin, J. et al. Prognostic importance of various echocardiographic right ventricular functional parameters in patients with symptomatic heart failure. J. Am. Soc. Echocardiogr. 18, 435\u2013444 (2005).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"BFnrcardio2010144_CR65","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.cardfail.2006.06.472","volume":"12","author":"ME Field","year":"2006","unstructured":"Field, M. E. et al. Right ventricular dysfunction and adverse outcome in patients with advanced heart failure. J. Card. Fail. 12, 616\u2013620 (2006).","journal-title":"J. Card. Fail."},{"key":"BFnrcardio2010144_CR66","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1161\/CIRCULATIONAHA.109.887570","volume":"121","author":"P Meyer","year":"2010","unstructured":"Meyer, P. et al. Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure. Circulation 121, 252\u2013258 (2010).","journal-title":"Circulation"},{"key":"BFnrcardio2010144_CR67","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jacc.2007.09.061","volume":"51","author":"SJ Lester","year":"2008","unstructured":"Lester, S. J. et al. Unlocking the mysteries of diastolic function: deciphering the Rosetta Stone 10 years later. J. Am. Coll. Cardiol. 51, 679\u2013689 (2008).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR68","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0735-1097(97)00344-6","volume":"30","author":"SF Nagueh","year":"1997","unstructured":"Nagueh, S. F., Middleton, K. J., Kopelen, H. A., Zoghbi, W. A. & Qui\u00f1ones, M. A. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J. Am. Coll. Cardiol. 30, 1527\u20131533 (1997).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR69","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.jacc.2009.12.034","volume":"55","author":"CS Lam","year":"2010","unstructured":"Lam, C. S. Heart failure with preserved ejection fraction: invasive solution to diagnostic confusion? J. Am. Coll. Cardiol. 55, 1711\u20131712 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR70","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.healun.2009.07.014","volume":"29","author":"CA Fiack","year":"2010","unstructured":"Fiack, C. A. & Farber, H. W. Pulmonary hypertension associated with left ventricular diastolic dysfunction. J. Heart Lung Transplant. 29, 230\u2013231 (2010).","journal-title":"J. Heart Lung Transplant."},{"key":"BFnrcardio2010144_CR71","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa040532","volume":"351","author":"LA Pi\u00e9rard","year":"2004","unstructured":"Pi\u00e9rard, L. A. & Lancellotti, P. The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. N. Engl. J. Med. 351, 1627\u20131634 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2010144_CR72","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.jacc.2009.04.088","volume":"54","author":"M Guazzi","year":"2009","unstructured":"Guazzi, M. Pulmonary hypertension in heart failure with preserved ejection fraction: any pathophysiological role of mitral regurgitation. J. Am. Coll. Cardiol. 54, 1191\u20131192 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR73","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0735-1097(92)90050-W","volume":"19","author":"A Costard-J\u00e4ckle","year":"1992","unstructured":"Costard-J\u00e4ckle, A. & Fowler, M. B. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J. Am. Coll. Cardiol. 19, 48\u201354 (1992).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR74","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0735-1097(96)00399-3","volume":"28","author":"MM Givertz","year":"1996","unstructured":"Givertz, M. M., Hare, J. M., Loh, E., Gauthier, D. F. & Colucci, W. S. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension. J. Am. Coll. Cardiol. 28, 1775\u20131780 (1996).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR75","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0735-1097(91)90832-T","volume":"17","author":"DW Kitzman","year":"1991","unstructured":"Kitzman, D. W., Higginbotham, M. B., Cobb, F. R., Sheikh, K. H. & Sullivan, M. J. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J. Am. Coll. Cardiol. 17, 1065\u20131072 (1991).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR76","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1161\/CIRCULATIONAHA.108.787101","volume":"118","author":"JJ Tolle","year":"2008","unstructured":"Tolle, J. J., Waxman, A. B., Van Horn, T. L., Pappagianopoulos, P. P. & Systrom, D. M. Exercise-induced pulmonary arterial hypertension. Circulation 118, 2183\u20132189 (2008).","journal-title":"Circulation"},{"key":"BFnrcardio2010144_CR77","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/eurheartj\/ehl561","volume":"28","author":"G Tumminello","year":"2007","unstructured":"Tumminello, G., Lancellotti, P., Lempereur, M., D'Orio, V. & Pierard, L. A. Determinants of pulmonary artery hypertension at rest and during exercise in patients with heart failure. Eur. Heart J. 28, 569\u2013574 (2007).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio2010144_CR78","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/S0735-1097(99)00408-8","volume":"34","author":"J Butler","year":"1999","unstructured":"Butler, J., Chomsky, D. B. & Wilson, J. R. Pulmonary hypertension and exercise intolerance in patients with heart failure. J. Am. Coll. Cardiol. 34, 1802\u20131806 (1999).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR79","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0002-8703(98)70121-8","volume":"136","author":"I Reindl","year":"1998","unstructured":"Reindl, I. et al. Impaired ventilatory efficiency in chronic heart failure: possible role of pulmonary vasoconstriction. Am. Heart J. 136, 778\u2013785 (1998).","journal-title":"Am. Heart J."},{"key":"BFnrcardio2010144_CR80","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/CIRCHEARTFAILURE.108.785501","volume":"1","author":"GD Lewis","year":"2008","unstructured":"Lewis, G. D., Shah, R. V., Pappagianopolas, P. P., Systrom, D. M. & Semigran, M. J. Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone. Circ. Heart Fail. 1, 227\u2013233 (2008).","journal-title":"Circ. Heart Fail."},{"key":"BFnrcardio2010144_CR81","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.jacc.2005.07.051","volume":"46","author":"M Guazzi","year":"2005","unstructured":"Guazzi, M., Myers, J. & Arena, R. Cardiopulmonary exercise testing in the clinical and prognostic assessment of diastolic heart failure. J. Am. Coll. Cardiol. 46, 1883\u20131890 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR82","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1161\/CIRCULATIONAHA.107.686576","volume":"115","author":"R Arena","year":"2007","unstructured":"Arena, R. et al. Development of a ventilatory classification system in patients with heart failure. Circulation 115, 2410\u20132417 (2007).","journal-title":"Circulation"},{"key":"BFnrcardio2010144_CR83","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jacc.2007.03.042","volume":"50","author":"M Guazzi","year":"2007","unstructured":"Guazzi, M. et al. Exercise oscillatory ventilation may predict sudden cardiac death in heart failure patients. J. Am. Coll. Cardiol. 50, 299\u2013308 (2007).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR84","doi-asserted-by":"crossref","first-page":"104.e1","DOI":"10.1016\/j.ahj.2006.10.003","volume":"153","author":"TP Olson","year":"2007","unstructured":"Olson, T. P. et al. Effects of acute changes in pulmonary wedge pressure on periodic breathing at rest in heart failure patients. Am. Heart J. 153, 104.e1\u2013104.e7 (2007).","journal-title":"Am. Heart J."},{"key":"BFnrcardio2010144_CR85","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1161\/01.CIR.99.12.1574","volume":"99","author":"P Solin","year":"1999","unstructured":"Solin, P. et al. Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 99, 1574\u20131579 (1999).","journal-title":"Circulation"},{"key":"BFnrcardio2010144_CR86","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-116-11-888","volume":"116","author":"SV Abramson","year":"1992","unstructured":"Abramson, S. V. et al. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann. Intern. Med. 116, 888\u2013895 (1992).","journal-title":"Ann. Intern. Med."},{"key":"BFnrcardio2010144_CR87","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/0735-1097(95)00587-0","volume":"27","author":"PR Rickenbacher","year":"1996","unstructured":"Rickenbacher, P. R. et al. Transplant candidates with severe left ventricular dysfunction managed with medical treatment: characteristics and survival. J. Am. Coll. Cardiol. 27, 1192\u20131197 (1996).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR88","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1053-2498(00)00138-8","volume":"19","author":"JD Hosenpud","year":"2000","unstructured":"Hosenpud, J. D., Bennett, L. E., Keck, B. M., Boucek, M. M. & Novick, R. J. The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report\u20142000. J. Heart Lung Transplant. 19, 909\u2013931 (2000).","journal-title":"J. Heart Lung Transplant."},{"key":"BFnrcardio2010144_CR89","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0002-9149(82)90183-7","volume":"50","author":"Y Yui","year":"1982","unstructured":"Yui, Y., Nakajima, H., Kawai, C. & Murakami, T. Prostacyclin therapy in patients with congestive heart failure. Am. J. Cardiol. 50, 320\u2013324 (1982).","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"BFnrcardio2010144_CR90","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/j.ijcard.2008.12.173","volume":"146","author":"Walter Serra","year":"2011","unstructured":"Serra, W., Musiari, L., Ardissino, D., Gherli, T. & Montanari, A. Benefit of prostaglandin infusion in severe heart failure: preliminary clinical experience of repetitive administration. Int. J. Cardiol. doi: 10.1016\/j.ijcard.2008.12.173.","journal-title":"International Journal of Cardiology"},{"key":"BFnrcardio2010144_CR91","doi-asserted-by":"crossref","first-page":"34A","DOI":"10.1016\/S0002-9149(99)80381-6","volume":"75","author":"CA Sueta","year":"1995","unstructured":"Sueta, C. A. et al. Safety and efficacy of epoprostenol in patients with severe congestive heart failure. Epoprostenol Multicenter Research Group. Am. J. Cardiol. 75, 34A\u201343A (1995).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio2010144_CR92","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/BF03017906","volume":"49","author":"A Sablotzki","year":"2002","unstructured":"Sablotzki, A. et al. Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension. Can. J. Anaesth. 49, 1076\u20131080 (2002).","journal-title":"Can. J. Anaesth."},{"key":"BFnrcardio2010144_CR93","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0002-8703(97)70105-4","volume":"134","author":"RM Califf","year":"1997","unstructured":"Califf, R. M. et al. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). Am. Heart J. 134, 44\u201354 (1997).","journal-title":"Am. Heart J."},{"key":"BFnrcardio2010144_CR94","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1161\/01.CIR.96.6.1976","volume":"96","author":"P Mulder","year":"1997","unstructured":"Mulder, P. et al. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling. Circulation 96, 1976\u20131982 (1997).","journal-title":"Circulation"},{"key":"BFnrcardio2010144_CR95","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0735-1097(97)00296-9","volume":"30","author":"A Wada","year":"1997","unstructured":"Wada, A. et al. Comparison of the effects of selective endothelin ETA and ETB receptor antagonists in congestive heart failure. J. Am. Coll. Cardiol. 30, 1385\u20131392 (1997).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR96","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/01.CIR.98.21.2262","volume":"98","author":"G S\u00fctsch","year":"1998","unstructured":"S\u00fctsch, G. et al. Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure. Circulation 98, 2262\u20132268 (1998).","journal-title":"Circulation"},{"key":"BFnrcardio2010144_CR97","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0167-5273(02)00182-1","volume":"85","author":"PR Kalra","year":"2002","unstructured":"Kalra, P. R., Moon, J. C. & Coats, A. J. Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure? Int. J. Cardiol. 85, 195\u2013197 (2002).","journal-title":"Int. J. Cardiol."},{"key":"BFnrcardio2010144_CR98","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cardfail.2004.05.006","volume":"11","author":"M Packer","year":"2005","unstructured":"Packer, M. et al. Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study. J. Card. Fail. 11, 12\u201320 (2005).","journal-title":"J. Card. Fail."},{"key":"BFnrcardio2010144_CR99","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000107791","volume":"109","author":"E Kaluski","year":"2008","unstructured":"Kaluski, E. et al. Clinical and hemodynamic effects of bosentan dose optimization in symptomatic heart failure patients with severe systolic dysfunction, associated with secondary pulmonary hypertension\u2014a multi-center randomized study. Cardiology 109, 273\u2013280 (2008).","journal-title":"Cardiology"},{"key":"BFnrcardio2010144_CR100","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/01.CIR.0000038497.80095.E1","volume":"106","author":"TF L\u00fcscher","year":"2002","unstructured":"L\u00fcscher, T. F. et al. Hemodynamic and neurohumoral effects of selective endothelin A (ETA) receptor blockade in chronic heart failure: the Heart Failure ETA Receptor Blockade Trial (HEAT). Circulation 106, 2666\u20132672 (2002).","journal-title":"Circulation"},{"key":"BFnrcardio2010144_CR101","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0140-6736(04)16723-8","volume":"364","author":"I Anand","year":"2004","unstructured":"Anand, I. et al. Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial. Lancet 364, 347\u2013354 (2004).","journal-title":"Lancet"},{"key":"BFnrcardio2010144_CR102","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1001\/jama.298.17.2009","volume":"298","author":"JJ McMurray","year":"2007","unstructured":"McMurray, J. J. et al. Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. JAMA 298, 2009\u20132019 (2007).","journal-title":"JAMA"},{"key":"BFnrcardio2010144_CR103","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1161\/01.CIR.101.25.2922","volume":"101","author":"MM Givertz","year":"2000","unstructured":"Givertz, M. M. et al. Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure. Circulation 101, 2922\u20132927 (2000).","journal-title":"Circulation"},{"key":"BFnrcardio2010144_CR104","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0003-4975(97)01307-6","volume":"65","author":"M Argenziano","year":"1998","unstructured":"Argenziano, M. et al. Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann. Thorac. Surg. 65, 340\u2013345 (1998).","journal-title":"Ann. Thorac. Surg."},{"key":"BFnrcardio2010144_CR105","first-page":"436","volume":"14","author":"N Kieler-Jensen","year":"1995","unstructured":"Kieler-Jensen, N., Lundin, S. & Ricksten, S. E. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside. J. Heart Lung Transplant. 14, 436\u2013443 (1995).","journal-title":"J. Heart Lung Transplant."},{"key":"BFnrcardio2010144_CR106","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/01.CIR.95.9.2250","volume":"95","author":"JM Hare","year":"1997","unstructured":"Hare, J. M. et al. Influence of inhaled nitric oxide on systemic flow and ventricular filling pressure in patients receiving mechanical circulatory assistance. Circulation 95, 2250\u20132253 (1997).","journal-title":"Circulation"},{"key":"BFnrcardio2010144_CR107","first-page":"366","volume":"13","author":"N Kieler-Jensen","year":"1994","unstructured":"Kieler-Jensen, N. et al. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. J. Heart Lung Transplant. 13, 366\u2013375 (1994).","journal-title":"J. Heart Lung Transplant."},{"key":"BFnrcardio2010144_CR108","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0002-9149(94)90496-0","volume":"74","author":"EA Bocchi","year":"1994","unstructured":"Bocchi, E. A. et al. Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure. Am. J. Cardiol. 74, 70\u201372 (1994).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio2010144_CR109","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(95)92681-X","volume":"346","author":"OI Miller","year":"1995","unstructured":"Miller, O. I., Tang, S. F., Keech, A. & Celermajer, D. S. Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide. Lancet 346, 51\u201352 (1995).","journal-title":"Lancet"},{"key":"BFnrcardio2010144_CR110","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/sj.bjp.0704984","volume":"137","author":"F Murray","year":"2002","unstructured":"Murray, F., MacLean, M. R. & Pyne, N. J. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension. Br. J. Pharmacol. 137, 1187\u20131194 (2002).","journal-title":"Br. J. Pharmacol."},{"key":"BFnrcardio2010144_CR111","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jacc.2009.05.021","volume":"54","author":"V Melenovsky","year":"2009","unstructured":"Melenovsky, V. et al. Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil. J. Am. Coll. Cardiol. 54, 595\u2013600 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR112","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","volume":"353","author":"N Gali\u00e8","year":"2005","unstructured":"Gali\u00e8, N. et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N. Engl. J. Med. 353, 2148\u20132157 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2010144_CR113","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1161\/CIRCHEARTFAILURE.108.802116","volume":"1","author":"M Guazzi","year":"2008","unstructured":"Guazzi, M. Clinical use of phosphodiesterase-5 inhibitors in chronic heart failure. Circ. Heart Fail. 1, 272\u2013280 (2008).","journal-title":"Circ. Heart Fail."},{"key":"BFnrcardio2010144_CR114","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.amjcard.2004.07.157","volume":"94","author":"J Alaeddini","year":"2004","unstructured":"Alaeddini, J. et al. Efficacy and safety of sildenafil in the evaluation of pulmonary hypertension in severe heart failure. Am. J. Cardiol. 94, 1475\u20131477 (2004).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio2010144_CR115","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1378\/chest.127.5.1647","volume":"127","author":"JJ Lepore","year":"2005","unstructured":"Lepore, J. J. et al. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide. Chest 127, 1647\u20131653 (2005).","journal-title":"Chest"},{"key":"BFnrcardio2010144_CR116","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1016\/j.jacc.2004.09.041","volume":"44","author":"M Guazzi","year":"2004","unstructured":"Guazzi, M., Tumminello, G., Di Marco, F., Fiorentini, C. & Guazzi, M. D. The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure. J. Am. Coll. Cardiol. 44, 2339\u20132348 (2004).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR117","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/CIRCULATIONAHA.106.626226","volume":"115","author":"GD Lewis","year":"2007","unstructured":"Lewis, G. D. et al. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure. Circulation 115, 59\u201366 (2007).","journal-title":"Circulation"},{"key":"BFnrcardio2010144_CR118","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.jacc.2007.07.078","volume":"50","author":"M Guazzi","year":"2007","unstructured":"Guazzi, M., Samaja, M., Arena, R., Vicenzi, M. & Guazzi, M. D. Long-term use of sildenafil in the therapeutic management of heart failure. J. Am. Coll. Cardiol. 50, 2136\u20132144 (2007).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR119","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/CIRCULATIONAHA.107.716373","volume":"116","author":"GD Lewis","year":"2007","unstructured":"Lewis, G. D. et al. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Circulation 116, 1555\u20131562 (2007).","journal-title":"Circulation"},{"key":"BFnrcardio2010144_CR120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cardfail.2007.11.006","volume":"14","author":"A Behling","year":"2008","unstructured":"Behling, A. et al. Effects of 5\u2032-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial. J. Card. Fail. 14, 189\u2013197 (2008).","journal-title":"J. Card. Fail."},{"key":"BFnrcardio2010144_CR121","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/CIRCHEARTFAILURE.108.796789","volume":"1","author":"RJ Tedford","year":"2008","unstructured":"Tedford, R. J. et al. PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ. Heart Fail. 1, 213\u2013219 (2008).","journal-title":"Circ. Heart Fail."},{"key":"BFnrcardio2010144_CR122","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cardfail.2008.09.005","volume":"15","author":"J Stehlik","year":"2009","unstructured":"Stehlik, J. & Movsesian, M. A. Combined use of PDE5 inhibitors and nitrates in the treatment of pulmonary arterial hypertension in patients with heart failure. J. Card. Fail. 15, 31\u201334 (2009).","journal-title":"J. Card. Fail."},{"key":"BFnrcardio2010144_CR123","first-page":"e391","volume":"119","author":"SA Hunt","year":"2009","unstructured":"Hunt, S. A. et al. 2009 focused update incorporated into the ACC\/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119, e391\u2013e479 (2009).","journal-title":"Circulation"},{"key":"BFnrcardio2010144_CR124","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.jacc.2010.01.022","volume":"55","author":"D Verhaert","year":"2010","unstructured":"Verhaert, D. et al. Long-term reverse remodeling with cardiac resynchronization therapy: results of extended echocardiographic follow-up. J. Am. Coll. Cardiol. 55, 1788\u20131795 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR125","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S1053-2498(03)00296-1","volume":"23","author":"JS Healey","year":"2004","unstructured":"Healey, J. S., Davies, R. A. & Tang, A. S. Improvement of apparently fixed pulmonary hypertension with cardiac resynchronization therapy. J. Heart Lung Transplant. 23, 650\u2013652 (2004).","journal-title":"J. Heart Lung Transplant."},{"key":"BFnrcardio2010144_CR126","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/j.jacc.2005.04.069","volume":"46","author":"GB Bleeker","year":"2005","unstructured":"Bleeker, G. B. et al. Left ventricular dyssynchrony predicts right ventricular remodeling after cardiac resynchronization therapy. J. Am. Coll. Cardiol. 46, 2264\u20132269 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2010144_CR127","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.amjcard.2007.07.064","volume":"101","author":"A Shalaby","year":"2008","unstructured":"Shalaby, A., Voigt, A., El-Saed, A. & Saba, S. Usefulness of pulmonary artery pressure by echocardiography to predict outcome in patients receiving cardiac resynchronization therapy heart failure. Am. J. Cardiol. 101, 238\u2013241 (2008).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio2010144_CR128","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jtcvs.2006.08.104","volume":"133","author":"D Zimpfer","year":"2007","unstructured":"Zimpfer, D. et al. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. J. Thorac. Cardiovasc. Surg. 133, 689\u2013695 (2007).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFnrcardio2010144_CR129","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.athoracsur.2007.01.019","volume":"83","author":"CD Etz","year":"2007","unstructured":"Etz, C. D. et al. Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices. Ann. Thorac. Surg. 83, 1697\u20131705 (2007).","journal-title":"Ann. Thorac. Surg."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2010.144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2010.144","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2010.144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:45:31Z","timestamp":1684467931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2010.144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,5]]},"references-count":129,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["BFnrcardio2010144"],"URL":"https:\/\/doi.org\/10.1038\/nrcardio.2010.144","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,5]]}}}